Long-term remission of extramedullary relapse from acute promyelocytic leukemia after treatment with arsenic trioxide, intrathecal chemotherapy, and brain irradiation

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 4, 2007, Pages 320-323

  Farhat, Mohamed ^a,b   Venugopal, Parameswaran ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID;

ADULT; ARTICLE; BONE MARROW BIOPSY; BRAIN METASTASIS; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; CHLOROMA; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; EXTERNAL AUDITORY CANAL; FATIGUE; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; GINGIVA BLEEDING; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LONG TERM CARE; MALAISE; MALE; MULTIPLE CYCLE TREATMENT; PANCYTOPENIA; PROMYELOCYTIC LEUKEMIA; SYSTEMIC THERAPY; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; CRANIAL IRRADIATION; DAUNORUBICIN; EAR NEOPLASMS; HUMANS; INJECTIONS, SPINAL; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; OXIDES; REMISSION INDUCTION; SARCOMA, GRANULOCYTIC; TRETINOIN;

EID: 34249107039     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Vickers M, Jackson G, Taylor P. The incidence ofacute promyelocytic leukemia appears constant over most of a human lifespan, implying one rate limiting mutation. Leukemia. 2000;14:722-726.
2. Fenaux P, Chomienne C, Degos L. Acute promyelocytic leukemia: biology and treatment. Semin Oncol. 1997;24:92-102.
3. Hu J, Shen ZK, Sun GL, et al. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and arsenic trioxide: an experience of 120 patients at a single institution. Int J Hematol. 1999;70:248-260.
4. de Botton S, Sanz MA, Chevret S, et al. Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia. 2006;20:35-41.
5. Wiernik PH, De Bellis R, Muxi P, et al. Extramedullary acute promyelocytic leukemia. Cancer. 1996;78:2510-2514.
6. Au WY, Chan GCF, Chim CS, et al. Unusual sites of involvement by hematologic malignancies case 3. External auditory canal tumor: A rare chloroma in acute promyelocytic leukemia with a complete response to arsenic trioxide. J Clinical Oncology. 2001;3993-3995.
7. Tallman MS, Andersen JW, Schiffer CA, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337:1021-1028.
8. Niu C, Yan H, Yu T, et al. Studies on treatment of acute promyclocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood. 1999;94:3315-3324.
9. Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994;83:10-25.
10. Warrell RP Jr, de The H, Wang ZY, et al. Acute promyelocytic leukemia. N Engl J Med. 1993;329(3):177-89.
11. Nervi C, Poindexter EC, Grignani F, et al. Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation. Cancer Res. 1992; 52:3687.
12. Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood. 1993;82:3241-3249.
13. Soignet SL, Maslak F, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998;339: 1341-1348.
14. Evans G, Grimwade D, Prentice HG, Simpson N. Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid. Br J Haematol. 1997;98:437-439.
15. Mathews V, Balasubramanian P, Shaji RV, George B, Chandy M, Srivastava A. Central nervous system relapse in a patient with acute promyelocycic leukaemia treated with arsenic tri-oxide. Br J Haematol. 2001;113:257-258.